Forecast: Basic Pharmaceutical Products and Pharmaceutical Preparations Turnover in Sweden

The turnover of basic pharmaceutical products and pharmaceutical preparations in Sweden showed a fluctuating trend from 2013 to 2018, with a notable decline from 2013 to 2017 and a rally in 2018. In 2020, the industry experienced a significant surge with growth rates surpassing 30%, followed by consistent year-on-year increases in the subsequent years, reaching a high of 25.78 billion Euros in 2023. The CAGR from 2018 to 2023 was 28.54%, indicating a robust market expansion.

Future trends to watch for:

Continued strong growth: The forecast suggests a steady average annual growth rate of 8.11% up to 2028, with a projected turnover of 43.37 billion Euros.

Increasing innovation in pharmaceuticals: Advancements in biotechnology and personalized medicine could drive further increases in market value.

Regulatory impacts: Changes in healthcare policies and drug approval processes might influence future turnover trends.